Piracetam Tablets

This product is a brain metabolism improving drug, which is a cyclic derivative of g-aminobutyric acid. It has an effect of resisting brain function damage caused by physical and chemical factors. It can promote ATP in the brain, promote acetylcholine synthesis and positively enhance the conduction of nerve excitation, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability. The acute toxicology test of animal experiments showed that the oral gavage dose of mice was greater than 10g/kg, and no death was found. The median lethal dose LD50 of intravenous administration is 9.2g/kg. Subacute and chronic toxicology experiments did not find any adverse effects on the growth and development of rats and dogs. It has no effect on important internal organs and functions such as blood, heart, liver, kidney, and brain.

The main ingredient of this product is: Piracetam. Its chemical name is: 2-oxidation-1-pyrrolidinyl acetamide. Molecular formula: C6H10N2O2 Molecular weight: 142.16

This product is white tablets.

It is suitable for memory loss and mild to moderate brain dysfunction caused by various reasons such as acute and chronic cerebrovascular diseases, brain trauma, various toxic encephalopathy, etc. It can also be used for children with intellectual retardation.

Oral administration. 0.8-1.6g (2-4 tablets) each time, 3 times a day, 4-8 weeks as a course of treatment. Children's dosage is halved.

Common adverse reactions to the digestive tract include nausea, abdominal discomfort, poor appetite, abdominal distension, abdominal pain, etc. The severity of the symptoms is directly related to the dosage. Adverse reactions to the central nervous system include excitement, irritability, dizziness, headache and insomnia, but the symptoms are mild and have nothing to do with the dosage. The above symptoms disappear after stopping the drug. Mild liver damage is occasionally seen, manifested as mild elevation of transaminase, but it is not related to the drug dosage.

Patients with extrapyramidal diseases and Huntington's chorea are prohibited from using this product to avoid aggravating the symptoms.

Precautions for children: Forbidden for newborns. Precautions for pregnancy and lactation: This product easily crosses the placental barrier, so it is forbidden for pregnant women; the indication for use in lactating women is not yet clear. Precautions for the elderly: Not yet clear.

When this product is used in combination with warfarin, it can prolong the prothrombin time and induce the inhibition of platelet aggregation. In patients receiving anticoagulant therapy, special attention should be paid to the coagulation time when piracetam is used at the same time to prevent the risk of bleeding, and the dosage and usage of the anticoagulant therapy should be adjusted.

Keep sealed.

0.4g

36 months

Competent Investments Limited

• Founded in:

  2002-01-21

• Address:

  No. 10, Chaquan Road, Yixing Environmental Science Park

• Tax NO.:

  913202827337569645

• Registered Funds:

  $1.62 million

• Website:

  Log in to view

• Email:

  Log in to view